A specialist travel insurance provider answers your questions on travel insurance for a child with a brain tumour.

The first in our series of virtual information events for parents and carers of a child with a brain tumour.

Last Friday (27th July), the findings of the National Cancer Patient Experience Survey 2017 (NCPES) were published.

The Parental Bereavement (Leave and Pay) Bill has just passed its third reading in the House of Lords and is expected to come into force in April 2020.

We are delighted to be finalists for Charity of the Year, Annual Report and Fundraising Event for the Third Sector Awards.

On Tuesday night, MPs in Westminster adopted an amendment to the Trade Bill which indicates support for the United Kingdom remaining in the regulatory framework of the European Medicines Agency (EMA)

Our Research Communications Assistant, Arshiya, gives an overview of the International Symposium on Paediatric Neuro-Oncology (ISPNO)

These guidelines, published today, have been updated for the first time in over a decade

Researchers from the Institute of Cancer Research discovered that tumour cells in paediatric high-grade gliomas work together to invade other structures of the brain

Today marks the 70th birthday of the National Health Service and The Brain Tumour Charity would like to celebrate all that it has done for our community

Results from a phase 1 clinical trial show that patients with recurrent glioblastoma treated with an inactive version of the polio virus live longer than those receiving standard treatment

New data presented at the recent American Association of Clinical Oncology (ASCO) meeting in Chicago by Abbvie, a pharmaceutical company, provides hope for those diagnosed with a glioblastoma

Last week the Government announced that people with severe, life-long conditions will no longer have to attend regular reviews for Personal Independence Payment (PIP).

Helena Brown, our Policy & Public Affairs Assistant, outlines the current postcode disparity in patient experience

Last week, Billy Caldwell, a severely epileptic twelve year old boy, had his cannabis oil confiscated at Heathrow airport

The research engagement team recently visited The Blizard Institute of Cell and Molecular Science in London and met with Dr Tom Millner

Keilan Arblaster, our Policy Involvement Assistant, outlines the implications of this bill for our community

A study led by researchers from Duke Cancer Institute identifies genetic markers to classify previously undetermined glioblastomas

Tonight we watched an emotional Panorama following three families as they contend with a high grade brain tumour diagnosis.

This Volunteers Week we’re celebrating each and every one of our 612 volunteers who are passionate about helping us achieve our goals.

Kielan Arblastar, our Policy & Affairs Assistant, discusses the implications of the US Government’s Right to Try bill

We have joined forces with other leading charities to form The Children and Young People Cancer Coalition and highlight areas where we believe progress is needed.

Early findings from a phase 3 clinical trial testing DCVax®-L, a dendritic cell treatment, show increased overall survival for patients with glioblastoma.

Recent clinical data reports that a new surgical approach could improve survival for individuals with difficult to access high-grade gliomas